Y-mAbs Therapeutics Inc. (YMAB)
5.20
-0.36 (-6.47%)
At close: Mar 03, 2025, 3:59 PM
5.15
-0.85%
After-hours: Mar 03, 2025, 06:41 PM EST
Y-mAbs Therapeutics Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 78.64M | 105.76M | 181.56M | 114.63M | 207.14M | 147.84M | 90.48M | 16.88M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 12.49M | 5.68M | 3.17M | 3.29M | 370K | 187K | 772K | n/a |
Receivables | 22.45M | 12.53M | 7.71M | n/a | n/a | n/a | n/a | n/a |
Inventory | 5.07M | 6.7M | 5.51M | -800K | n/a | n/a | n/a | n/a |
Other Current Assets | 4.96M | 5.45M | 7.47M | 7.73M | 4.82M | 3.69M | 872K | 386K |
Total Current Assets | 111.11M | 130.45M | 202.26M | 122.36M | 211.96M | 151.53M | 91.36M | 17.26M |
Property-Plant & Equipment | 1.64M | 2.34M | 5.69M | 6.39M | 4.04M | 205K | n/a | n/a |
Goodwill & Intangibles | 2.63M | 2.99M | 1.66M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 16.76M | 11.01M | 10.52M | 9.68M | 4.41M | 392K | 772K | n/a |
Total Assets | 127.87M | 141.46M | 212.78M | 132.05M | 216.37M | 151.92M | 92.13M | 17.26M |
Account Payables | 6.06M | 14.18M | 13.55M | 9.37M | 8.52M | 5.87M | 5.91M | 2.23M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 902K | 1.74M | 3.57M | 3.93M | 1.03M | n/a | n/a | n/a |
Other Current Liabilities | 13.17M | 12.37M | 10.76M | 6.23M | 4.03M | 3.25M | 2.02M | 748K |
Total Current Liabilities | 20.13M | 28.28M | 27.88M | 19.54M | 13.59M | 9.12M | 7.92M | 2.98M |
Long-Term Debt | 517K | 899K | 1.85M | 2.01M | 1.71M | n/a | n/a | n/a |
Other Long-Term Liabilities | 6.24M | 3.05M | 2.95M | 4.66M | 2.16M | 2.27M | 2.05M | 2.23M |
Total Long-Term Liabilities | 6.76M | 3.95M | 4.8M | 6.68M | 3.88M | 2.27M | 2.05M | 2.23M |
Total Liabilities | 26.88M | 32.23M | 32.68M | 26.21M | 17.46M | 11.4M | 9.97M | 5.2M |
Total Debt | 1.42M | 1.77M | 3.63M | 3.98M | 2.23M | n/a | n/a | n/a |
Common Stock | 4K | 4K | 4K | 4K | 4K | 3K | 3K | 2K |
Retained Earnings | -457.47M | -436.04M | -340.48M | -285.2M | -165.86M | -84.83M | -41.56M | -22.4M |
Comprehensive Income | 449K | 1.33M | 1.37M | -526K | 50K | 7K | -169K | 30K |
Shareholders Equity | 100.98M | 109.22M | 180.11M | 105.84M | 198.9M | 140.53M | 82.15M | 12.06M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |